23 Heart Attack Clinical Trials in Stanford, CA (2026)

Q: How do I join a clinical trial in Stanford?

Browse available studies, click one that interests you, and complete the free eligibility form. A study coordinator at the Stanford research site will contact you.

Recruiting Heart Attack Studies in Stanford

NCT06289985Recruiting

StrokeNet Thrombectomy Endovascular Platform

STEP is a Randomized, Multifactorial, Adaptive Platform trial that seeks to optimize the care of patients with acute ischemic stroke (AIS) due to large (LVO) or medium vessel occlusions (MVO)....

Stanford, CANA1,600 participantsMedical University of South Carolina

View Study Details

NCT03242642Recruiting

Transcatheter Mitral Valve Replacement With the Medtronic Intrepid™ TMVR System in Patients With Severe Symptomatic Mitral Regurgitation.

Multi-center, global, prospective, non-randomized, interventional, pre-market trial. All subjects enrolled with receive the study device....

Stanford, CANA1,056 participantsMedtronic Cardiovascular

View Study Details

NCT01694940Recruiting

North American Mitochondrial Disease Consortium Patient Registry and Biorepository (NAMDC)

The North American Mitochondrial Disease Consortium (NAMDC) maintains a patient contact registry and tissue biorepository for patients with mitochondrial disorders....

Stanford, CA1,000 participantsColumbia University

View Study Details

NCT01804686Recruiting

A Long-term Extension Study of PCI-32765 (Ibrutinib)

The purpose of this study is to collect long-term safety and efficacy data for participants treated with ibrutinib and to provide ongoing access to ibrutinib for participants who are currently enrolle...

Stanford, CAPHASE3700 participantsJanssen Research & Development, LLC

View Study Details

NCT04064060Recruiting

A Study to Evaluate Long-term Safety in Participants Who Have Participated in Other Luspatercept (ACE-536) Clinical Trials

A Phase 3b, open-label, single-arm, rollover study to evaluate the long-term safety of luspatercept, to the following participants: * Participants receiving luspatercept on a parent protocol at the t...

Stanford, CAPHASE3665 participantsCelgene

View Study Details

NCT04500756Recruiting

Limiting AAA With Metformin (LIMIT) Trial

In this research, the investigators are looking at the effects of a drug called metformin may have on the growth of abdominal aortic aneurysm (AAA)s. AAA is an abnormal enlargement of the aorta, which...

Stanford, CAPHASE2314 participantsStanford University

View Study Details

NCT03802695Recruiting

A Phase 1 Study of Orca-Q in Recipients Undergoing Allogeneic Transplantation for Hematologic Malignancies

This study will evaluate the safety, tolerability, and efficacy of engineered donor grafts ("OrcaGraft"/"Orca-Q") in participants undergoing allogeneic hematopoietic cell transplant (alloHCT) transpla...

Stanford, CAPHASE1300 participantsOrca Biosystems, Inc.

View Study Details

NCT07103733Recruiting

PRIMARY Ancillary Substudy

The PRIMARY trial (NCT05051033), which compares mitral valve repair (MVr) to transcatheter-edge-to-edge-repair (TEER), offers a platform for conducting mechanistic studies to develop early insights in...

Stanford, CANA250 participantsAnnetine Gelijns

View Study Details

NCT06735885Recruiting

fMRI Neurofeedback With Matter Neuroscience App

Study will utilize an app, Matter Neuroscience, designed to help users with depression understand positive emotions and the neurotransmitters that create them. We hope to learn the safety and efficacy...

Stanford, CANA240 participantsStanford University

View Study Details

NCT06897930Recruiting

A Study to Investigate the Safety, Tolerability, and Efficacy of AZD0120 in Adults With Refractory SLE

This is a Phase 1b/2, single-arm, open-label, multi-center, clinical study of AZD0120, a CD19/BCMA dual CAR T cell therapy, to evaluate the safety, tolerability, and efficacy in adult participants wit...

Stanford, CAPHASE1150 participantsAstraZeneca

View Study Details

NCT04996875Recruiting

(Apex) Bezuclastinib in Patients With Advanced Systemic Mastocytosis

This is an open-label, two-part Phase 2 study investigating CGT9486 for the treatment of patients with Advanced Systemic Mastocytosis (AdvSM), including patients with Aggressive SM (ASM), SM with Asso...

Stanford, CAPHASE2140 participantsCogent Biosciences, Inc.

View Study Details

NCT06950034Recruiting

A Phase 1 Study of STX-0712 in Patients With Advanced Hematological Malignancies (CMML and AML)

This is a first-in-human, multicenter, open-label, phase 1 study to evaluate the safety, PK, PD and preliminary efficacy of STX-0712 in patients with advanced CMML and AML for whom there are no furthe...

Stanford, CAPHASE1105 participantsSolu Therapeutics, Inc

View Study Details

NCT07086976Recruiting

A Study to Investigate the Efficacy, Safety, and Pharmacokinetics of Oral Rilzabrutinib Compared With Placebo in Participants 18 Years of Age and Older With Warm Autoimmune Hemolytic Anemia

This is a parallel-group, Phase 3, double-blind, 2-arm study to investigate the efficacy, safety, PK and PD of oral rilzabrutinib in achieving durable Hb response (DHR) compared with placebo in approx...

Stanford, CAPHASE390 participantsSanofi

View Study Details

NCT06456463Recruiting

A Study of Tagraxofusp in Combination With Venetoclax and Azacitidine in Adults With Untreated CD123+ Acute Myeloid Leukemia Who Cannot Undergo Intensive Chemotherapy

This study will be divided into 2 parts (Part 1 and Part 2). Part 1 will evaluate 2 doses of tagraxofusp (9 and 12 micrograms/kilogram/day \[μg/kg/day\]), used in combination with venetoclax and azaci...

Stanford, CAPHASE283 participantsStemline Therapeutics, Inc.

View Study Details

NCT04159103Recruiting

Open-Label Study of mRNA-3927 in Participants With Propionic Acidemia

This 3-part, Phase 1/2 study is designed to characterize the safety, tolerability, and pharmacological activity (as assessed by biomarker measurements) and to determine the selected dose of mRNA-3927 ...

Stanford, CAPHASE177 participantsModernaTX, Inc.

View Study Details

NCT05769621Recruiting

A Retrospective Study to Characterize Participants With Propionic Acidemia

This is a non-interventional, observational, global, multicenter, study describing participant characteristics, clinical outcomes, and event rates in participants with propionic acidemia (PA)....

Stanford, CA60 participantsModernaTX, Inc.

View Study Details

NCT06517641Recruiting

Clinical Trial of Upfront Haploidentical or Unrelated Donor BMT to Restore Normal Hematopoiesis in Aplastic Anemia

BMT CTN 2207 will investigate the use of marrow transplantation for treatment of severe aplastic anemia that has not previously been treated....

Stanford, CAPHASE260 participantsMedical College of Wisconsin

View Study Details

NCT04615546Recruiting

Role of Nutrient Transit in Hyperinsulinemic Hypoglycemia

Severe hypoglycemia (low blood sugar)after gastric bypass surgery is an increasingly recognized condition, characterized by symptoms of hypoglycemia after eating and inappropriately elevated insulin c...

Stanford, CANA60 participantsStanford University

View Study Details

NCT04392622Recruiting

d-Limonene +Radiation +PlatinumBasedChemo for Xerostomia Prevention in LocallyAdvanced HNSCC

This study explores the safety of d-limonene, a commercially-available dietary supplement (food) as a potential therapeutic for the severe dry mouth (xerostomia) experienced by patients with head and ...

Stanford, CAPHASE140 participantsStanford University

View Study Details

NCT05101551Recruiting

Study of Talazoparib in Combination With Chemotherapy in Relapsed Pediatric AML to Determine Safety and Efficacy

This is a Phase 1, open label, multicenter, dose finding study with dose expansion intended to evaluate the safety and tolerability of talazoparib in combination with conventional chemotherapy. Prelim...

Stanford, CAPHASE134 participantsNorman J. Lacayo

View Study Details

NCT07295847Recruiting

A Study of AZD0120 in Autoimmune Diseases

This trial is a Phase 1b, open-label, multi-center, clinical study of AZD0120, a BCMA/CD19 dual targeting CAR+ T-cell therapy, to evaluate the safety and tolerability in adult participants with system...

Stanford, CAPHASE127 participantsAstraZeneca

View Study Details

NCT06216886Recruiting

OnabotulinumtoxinA for Trigeminal Neuralgia

A randomized controlled trial comparing Onabotulinumtoxin A to saline (placebo) for Trigeminal Neuralgia....

Stanford, CAPHASE420 participantsStanford University

View Study Details

NCT04784052Recruiting

Depleted Donor Stem Cell Transplant in Children and Adults With Fanconi Anemia After Being Conditioned With a Regimen Containing Briquilimab

The objective of this clinical trial is to develop a cell therapy for Fanconi Anemia which enables enhanced donor hematopoietic and immune reconstitution with decreased toxicity by transplanting deple...

Stanford, CAPHASE118 participantsPorteus, Matthew, MD

View Study Details

About Heart Attack Clinical Trials in Stanford

A heart attack (myocardial infarction) occurs when blood flow to part of the heart muscle is blocked, usually by a blood clot. It is a medical emergency requiring immediate treatment. Long-term management includes medications, lifestyle changes, and cardiac rehabilitation.

There are currently 23 heart attack clinical trials recruiting participants in Stanford, CA. These studies are seeking a combined 7,089 participants. Research is being sponsored by Medical University of South Carolina, Medtronic Cardiovascular, Columbia University and 14 other organizations. Clinical trial participation is free and participants receive study-related medical care at no cost.

Heart Attack Clinical Trials in Stanford — FAQ

Are there heart attack clinical trials in Stanford?

Yes, there are 23 heart attack clinical trials currently recruiting in Stanford, CA. Browse the studies on this page to find one that fits.

How do I join a clinical trial in Stanford?

Browse the studies listed above, click one that interests you, and complete the free eligibility form. A study coordinator at the Stanford research site will contact you about next steps.

Are clinical trials in Stanford free?

Yes, clinical trial participation is always free. Study-related treatment, medical tests, and doctor visits are provided at no cost. Many Stanford studies also compensate for your time and travel.

What heart attack treatments are being tested?

The 23 active trials in Stanford are testing new therapies including novel drugs, biologics, and treatment approaches for heart attack.

Data updated July 18, 2026 from ClinicalTrials.gov